Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan-Mar;13(1):23-28.
doi: 10.4103/ijabmr.ijabmr_378_22. Epub 2023 Mar 27.

Salivary 1,5-Anhydroglucitol and its Correlation with Postprandial Hyperglycemia: Development and Validation of a Novel Assay

Affiliations

Salivary 1,5-Anhydroglucitol and its Correlation with Postprandial Hyperglycemia: Development and Validation of a Novel Assay

Priyadarshini Subramaniam Kedarnath et al. Int J Appl Basic Med Res. 2023 Jan-Mar.

Abstract

Background: Saliva has the potential to be used as a noninvasive sample for testing hyperglycemia in diabetes mellitus. Serum 1,5-anhydroglucitol (1,5-AG) decreases with an increase in blood sugar >180 mg/dl. We hypothesized that salivary 1,5-AG can be used to identify blood sugar higher than 180 mg/dl using a novel biochemical method.

Aim: This study aimed to develop a novel biochemical method for serum and salivary assessment of 1,5-AG and assess its correlation with postprandial blood sugar (PPBS) >180 mg/dl.

Methodology: The study comprised 45 controls (healthy individuals) and 45 cases (type 2 diabetic patients with PPBS >180 mg/dl). Blood and salivary samples were collected according to the study protocol. A new method was developed for the quantification of 1,5-AG in serum and saliva using liquid chromatography-mass spectrometry.

Results: The value of serum (mean -22.19 μg/ml and median -22.12 μg/ml) and salivary (mean -0.124 μg/ml and median -0.088 μg/ml) 1,5-AG was higher in healthy individuals compared to corresponding serum (mean -3.89 μg/ml and median -2.52 μg/ml) and salivary (mean -0.025 μg/ml and median - 0.025 μg/ml) levels in diabetics with PPBS >180 mg/dl. In diabetics, a significant negative correlation was noticed with PPBS levels and 1,5-AG levels in serum and saliva. Salivary 1,5-AG level <0.054 μg/ml had an 86.4% sensitivity and 87.2% specificity in predicting a blood sugar value >180 mg/dl.

Conclusion: The results of our study suggest that the short-term glycemic marker 1,5-AG can be detected in saliva and can be useful as an adjunct marker in monitoring of glycemic status in diabetic patients.

Keywords: Liquid chromatography–mass spectrometry; salivary 1,5-anhydroglucitol; salivary biomarker; short-term glycemic marker; tandem mass spectrometry; type II diabetes mellitus.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Correlation between serum and salivary 1,5-AG with X-axis plotted with serum 1,5-AG levels and Y-axis plotted with salivary 1,5-AG levels. 1,5-AG: 1,5-anhydroglucitol
Figure 2
Figure 2
Correlation between serum 1,5-AG levels and PPBS values. X-axis is plotted with PPBS values and Y-axis with serum 1,5-AG levels. 1,5-AG: 1,5-anhydroglucitol. PPBS: Postprandial blood sugar
Figure 3
Figure 3
Correlation between salivary 1,5-AG levels and PPBS values. X-axis plotted with PPBS values and Y-axis with salivary 1,5-AG levels. 1,5-AG: 1,5-anhydroglucitol. PPBS: Postprandial blood sugar
Figure 4
Figure 4
Receiver operating characteristics of diagnostic accuracy parameters of salivary 1,5-AG compared with serum 1,5-AG as reference standard. 1,5-AG: 1,5-anhydroglucitol

References

    1. Kaufman E, Lamster IB. The diagnostic applications of saliva –A review. Crit Rev Oral Biol Med. 2002;13:197–212. - PubMed
    1. Pink R, Simek J, Vondrakova J, Faber E, Michl P, Pazdera J, et al. Saliva as a diagnostic medium. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2009;153:103–10. - PubMed
    1. Armbruster DA. Fructosamine:Structure, analysis, and clinical usefulness. Clin Chem. 1987;33:2153–63. - PubMed
    1. Wright LA, Hirsch IB. The challenge of the use of glycemic biomarkers in diabetes:Reflecting on hemoglobin A1C, 1,5-anhydroglucitol, and the glycated proteins fructosamine and glycated albumin. Diabetes Spectr. 2012;25:141–8.
    1. Dungan KM, Buse JB, Largay J, Kelly MM, Button EA, Kato S, et al. 1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes. Diabetes Care. 2006;29:1214–9. - PubMed